Keywords
epidemiology
Paraná
How to Cite
Abstract
Acute rheumatic fever is a multisystemic disease resulting from an autoimmune reaction to group A streptococcal infection. Along with rheumatic heart disease, it is associated with poverty and was prevalent in all countries until the 20th century. The aim of this study is to analyze the epidemiology of acute rheumatic fever cases in the state of Paraná, covering the period from 2014 to 2024. This is an ecological, descriptive, quantitative, and retrospective study, in which Hospital Morbidity data from the Brazilian Unified Health System (SUS) of patients reported with acute rheumatic fever from January 2014 to March 2024 in the state of Paraná were analyzed using data from the SUS Information Technology Department database. During this period, in the state of Paraná, the study sample included a total of 625 patients who were diagnosed and hospitalized due to acute rheumatic fever. The total cost of these hospitalizations reached R$ 530,845.59, reflecting the considerable economic burden imposed by the disease, with an average cost per Hospital Admission Authorization of R$ 849.36. Analysis of mortality data related to hospitalizations shows a total of 27 deaths. It is possible to conclude that acute rheumatic fever represents a significant challenge for the healthcare system in the state of Paraná, both in terms of incidence and financial impact and mortality. The analysis revealed a balanced distribution between genders, with a predominance of cases in white patients and a direct relationship between age group and number of diagnoses. The Eastern macro-region of the state was the most affected, which may be attributed to its higher population density and concentration of healthcare services, facilitating access to diagnosis and treatment.
References
ABOYANS, Victor et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet (British edition), v. 385, n. 9963, p. 117-71, 2015.
BRADLEY-HEWITT, T. et al. Trends and presentation patterns of acute rheumatic fever hospitalisations in the United States. Cardiology in the young, v. 29, n. 11, p. 1387–1390, 2019.
CARAPETIS, Jonathan R. et al. Acute rheumatic fever and rheumatic heart disease. Nature reviews Disease primers, v. 2, n. 1, p. 1-24, 2016.
COSTA, L. P.; DOMICIANO, D. S.; PEREIRA, R. M. R. Características demográficas, clínicas, laboratoriais e radiológicas da febre reumática no Brasil: revisão sistemática. Revista brasileira de reumatologia, v. 49, n. 5, p. 617–622, 2009.
DAS, D.; KRISHNA, S. The Descriptive Epidemiology of Acute Rheumatic Fever and Rheumatic Heart Disease in Low and Middle-Income Countries. v. 1, p. 34–40, 2013.
DATASUS. Departamento de Informática do SUS. [acesso em 06 jun. 2024]. Disponível em: https://datasus.saude.gov.br/.
ESPIRITO SANTO FREIRE, K. D. et al. Valve surgery: Results of the Brazilian Public Health System. Brazilian Journal of Medicine and Human Health, v. 2, n. 2, 2014.
JAMESON, J. Larry et al. Medicina Interna de Harrison-2 Volumes-20. McGraw Hill Brasil, 2019.
LEE, G. M.; WESSELS, M. R. Changing epidemiology of acute rheumatic fever in the United States. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, v. 42, n. 4, p. 448–450, 2006.
LONGENECKER, C. T. Rheumatic fever in Brazil: What color should it be? Arquivos brasileiros de cardiologia, 2019.
NASCIMENTO, B. R. et al. Comparison between different strategies of rheumatic heart disease echocardiographic screening in Brazil: Data from the PROVAR (Rheumatic Valve Disease Screening Program) study. Journal of the American Heart Association, v. 7, n. 4, 2018.
NEGI, P. C. et al. Gender differences in the epidemiology of Rheumatic Fever/Rheumatic heart disease (RF/RHD) patient population of hill state of northern India; 9 years prospective hospital based, HP-RHD registry. Indian heart journal, v. 72, n. 6, p. 552–556, 2020.
OU, Z. et al. Global burden of rheumatic heart disease: trends from 1990 to 2019. Arthritis research & therapy, v. 24, n. 1, 2022.
PICHICHERO, M. Treatment and prevention of streptococcal pharyngitis in adults and children. UpToDate. Retrieved June 12, 2024. From https://www.uptodate.com/contents/treatment-and-prevention-of-streptococcal-pharyngitis-in-adults-and-children.
RUAN, R. et al. Global, regional, and national advances toward the management of rheumatic heart disease based on the Global Burden of disease study 2019. Journal of the American Heart Association, v. 12, n. 13, 2023.
SARAIVA, L. R. et al. On the gravity of the acute rheumatic fever in children from pernambuco, Brazil. Arquivos brasileiros de cardiologia, 2013.
SAWHNEY, H. et al. Maternal and perinatal outcome in rheumatic heart disease. International Journal of Gynecology & Obstetrics, v. 80, n. 1, p. 9-14, 2003.
STEER, A. GIBOFSKY, A. Acute rheumatic fever: Treatment and prevention. UpToDate. Retrieved June 12, 2024. From https://www.uptodate.com/contents/acute-rheumatic-fever-treatment-and-prevention.
WAUCHOP, K. et al. The epidemiology of acute rheumatic fever in Northland, 2012–2017. Heart, lung & circulation, v. 28, p. S55, 2019.
ZÜHLKE, L. Management and prevention of rheumatic heart disease. UpToDate. Retrieved June 12, 2024. From https://www.uptodate.com/contents/management-and-prevention-of-rheumatic-heart-disease.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Danniely Alencar Sandim de Melo, Dr. James Albiero, Adrielli Bertotti, Ana Laura Toretta, Anna Julia Wunsch Dias, Bruna Araújo Nicézio, Kaoanna Taynara Dos Anjos Da Silva, Márcio Shikasho Júnior, Natália Regina Vieira Iacono